Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis

Publicado en línea: 13 jul 2022

Páginas: 70 - 73

Recibido: 18 ene 2022

Aceptado: 11 may 2022

DOI: https://doi.org/10.2478/jbcr-2022-0009

Palabras clave

bladder cancer, intravesical therapy, epirubicin, BCG

© 2022 Nikolay I. Nikolov et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.